BNTX
BioNTech SE
98.50$
-0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 81.6% | 50.6% | 68.8% | 70.2% | 71.9% | 95.2% | 94.2% | 84.9% | 83.5% | 73.4% | |
| 77.9% | 45.9% | 63.0% | 65.1% | 52.2% | 10.7% | 59.6% | 50.7% | 43.3% | 34.9% | |
| 78.3% | 46.0% | 63.1% | 65.3% | 58.1% | 13.1% | 60.4% | 71.9% | 74.5% | 67.5% | |
| 1.5% | 1.2% | 4.4% | 2.5% | 7.1% | 78.2% | 30.7% | 10.2% | 6.8% | 4.5% | |
| 0.8% | 1.0% | 0.9% | 1.5% | 2.8% | 3.2% | 1.9% | 1.6% | 1.3% | 0.5% | |
| 0.0% | 27.1% | 17.8% | 18.6% | 14.1% | 3.3% | – | – | – | – | |
| 0.1% | 0.1% | 0.1% | 0.4% | 2.3% | 0.4% | 0.3% | 1.6% | 1.7% | 1.7% | |
| 2.7% | 22.2% | 13.4% | 10.8% | 4.5% | 0.9% | 0.7% | 3.5% | 3.5% | 7.3% | |
| 91.8% | 112.9% | 59.1% | 38.1% | 40.8% | 24.9% | 13.8% | 12.0% | 13.8% | 12.6% | |
| 14.5% | 42.3% | 19.3% | 17.3% | 26.1% | 22.0% | 12.7% | 9.0% | 11.2% | 9.7% | |
| 0.8% | 5.2% | 1.0% | 1.0% | 0.4% | 0.8% | 0.2% | 0.1% | 0.2% | 0.2% | |
| 1.6% | 14.0% | 6.4% | 2.6% | 4.4% | 1.0% | 0.9% | 1.5% | 1.9% | 2.4% | |
| 0.0% | 0.0% | 0.9% | 8.6% | 10.0% | 1.1% | 0.8% | 0.8% | 1.0% | 1.0% | |
| 7.8% | -13.2% | 40.8% | 61.9% | 59.2% | 75.1% | 86.2% | 88.0% | 86.2% | 87.4% | |
| -28.7% | -52.8% | -37.6% | -53.3% | -17.7% | 62.4% | 80.9% | 85.9% | 84.8% | 81.7% | |
| 0.0% | 60.5% | 34.7% | 26.5% | 10.7% | 1.6% | 1.1% | 1.1% | 1.1% | 1.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.